Literature DB >> 1907998

Mechanism of cytolytic T lymphocyte killing of a low class I-expressing tumor.

T M Blieden1, A J McAdam, J G Frelinger, E M Lord.   

Abstract

Many tumors have been shown to express minimal levels of class I MHC Ag, which makes them more resistant to recognition and lysis by cytolytic T lymphocytes. Line 1, a BALB/c spontaneous lung carcinoma, normally expresses very low levels of class I Ag, but expression can be increased 50-fold by treatment with agents such as DMSO or IFN-gamma. Because class I Ag serve as restricting elements for cytolytic T cell recognition of tumor Ag, we wished to determine if cytotoxic T lymphocytes could play a role in the immune response to this type of class I low, but inducible, tumor. After immunization in vivo and restimulation of splenic cells in vitro we were able to generate T cell clones that lysed line 1 cells induced to express high levels of class I, but did not lyse uninduced, low class I expressing line 1 cells in short term (6-h) 51Cr release assays. Paradoxically, incubation of the T cells with uninduced class I low line 1 cells for a few days resulted in complete destruction of the tumor cells. We demonstrate that the T cells, stimulated by the tumor cells, produce IFN-gamma, which in turn induces class I expression on the line 1 cells making them susceptible to lysis by the T cell clone. This suggests that a positive feedback reaction can occur in generating a response to this and perhaps other inducible tumor cell lines.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1907998

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  Direct identification of tumor-associated peptide antigens.

Authors:  V H Engelhard
Journal:  Springer Semin Immunopathol       Date:  1996

2.  Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes.

Authors:  S Kurosawa; M Harada; G Matsuzaki; Y Shinomiya; H Terao; N Kobayashi; K Nomoto
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

3.  IFN-γ mediates the antitumor effects of radiation therapy in a murine colon tumor.

Authors:  Scott A Gerber; Abigail L Sedlacek; Kyle R Cron; Shawn P Murphy; John G Frelinger; Edith M Lord
Journal:  Am J Pathol       Date:  2013-04-12       Impact factor: 4.307

4.  Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells.

Authors:  B A Pulaski; K Y Yeh; N Shastri; K M Maltby; D P Penney; E M Lord; J G Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

5.  IL-12 suppresses vascular endothelial growth factor receptor 3 expression on tumor vessels by two distinct IFN-gamma-dependent mechanisms.

Authors:  Elizabeth W Sorensen; Scott A Gerber; John G Frelinger; Edith M Lord
Journal:  J Immunol       Date:  2010-01-08       Impact factor: 5.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.